Article

Ambiguous Mammograms: An Emotional and Financial Burden

A study published in a supplement to the Journal of Women's Health looks to the widespread impact of newer screening technologies to improve outcomes.

breast cancer

One of every 7 women who undergo annual mammography screening for will be called back for follow-up tests.

These women can worry for days or weeks that the "suspicious" finding the radiologist has seen on their mammogram will be cancer. They might also incur direct and indirect medical costs.

A supplement to the September issue of the Journal of Women's Health highlights the burden, both financial and personal, of screening recall, and outlines some of the newer technologies for imaging the breast that could improve the accuracy of screening and make it more cost efficient.

breast cancer screening

"Our goal in is to find the most cancers at the lowest cost," Susan C. Harvey, MD, from Johns Hopkins Medical Institutions in Baltimore, told Medscape Medical News. "We want to up our value."

Link to report on Medscape: http://bit.ly/1mYRNe0

Related Videos
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Cathy Eng, MD, FACP, FASCO
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Screenshot of an interview with Shaun McKenzie, MD
Screenshot of an interview with Shaun McKenzie, MD
Screenshot of an interview with Rohan Garje, MD
Susan Escudier, MD, FACP
Sabarish Ayyappan, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo